A sign sits outside of Karas Health Care in Fayetteville promoting a paid COVID-19 prevention drug study. The study does not involve ivermectin, but instead is a partnership with Adagio Therapeutics to perform a clinical trial testing whether monoclonal antibodies are an effective preventative treatment for COVID-19.
Fayetteville Clinic is Site of COVID Prevention Drug Study
Matthew Moore
/
KUAF
